- Apricus Biosciences (APRI) is up 27% premarket on light volume in response to its announcement that it has completed the sale of ex.U.S. rights to ED topical cream Vitaros to Ferring International.
- Previously: Apricus completes sale of ex-U.S. rights to Vitaros to Ferring (March 8)
Apricus completes sale of ex-U.S. rights to Vitaros; shares ahead 27% premarket
Recommended For You
About SEEL Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| SEEL | - | - |
| Seelos Therapeutics, Inc. | ||